 A second Massachusetts compounding pharmacy surrendered its license after state inspectors found significant issues that could affect sterility, state health officials said.
 Massachusetts Gov.
 Infusion Resource is not linked to the outbreak.
 FDA: Drug maker had internal warnings months before meningitis outbreak.
 The state Board of Pharmacy immediately issued a cease and desist notice to Infusion Resource after the October 23 inspection revealed the violations, she said.
 What is a compounding pharmacy?.
 